Annual ROE
-31.53%
-10.76%-51.81%
31 December 2023
Summary:
Lyell Immunopharma annual return on equity is currently -31.53%, with the most recent change of -10.76% (-51.81%) on 31 December 2023. During the last 3 years, it has risen by +4.77% (+13.14%). LYEL annual ROE is now -51.81% below its all-time high of -20.77%, reached on 31 December 2022.LYEL ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-33.41%
-1.15%-3.56%
30 September 2024
Summary:
Lyell Immunopharma quarterly return on equity is currently -33.41%, with the most recent change of -1.15% (-3.56%) on 30 September 2024. Over the past year, it has dropped by -8.86% (-36.09%). LYEL quarterly ROE is now -58.12% below its all-time high of -21.13%, reached on 31 December 2022.LYEL Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LYEL ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -51.8% | -36.1% |
| 3 y3 years | +13.1% | -38.5% |
| 5 y5 years | - | - |
LYEL ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -51.8% | +13.1% | -58.1% | at low |
| 5 y | 5 years | -51.8% | +13.1% | -58.1% | at low |
| alltime | all time | -51.8% | +13.1% | -58.1% | at low |
Lyell Immunopharma ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -33.41%(+3.6%) |
| June 2024 | - | -32.26%(-1.8%) |
| Mar 2024 | - | -32.84%(+3.8%) |
| Dec 2023 | -31.53%(+51.8%) | -31.65%(+28.9%) |
| Sept 2023 | - | -24.55%(-5.3%) |
| June 2023 | - | -25.92%(+19.3%) |
| Mar 2023 | - | -21.73%(+2.8%) |
| Dec 2022 | -20.77% | -21.13%(-26.7%) |
| Sept 2022 | - | -28.81%(+13.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | -25.29%(-13.6%) |
| Mar 2022 | - | -29.28%(+1.4%) |
| Dec 2021 | -30.36%(-16.4%) | -28.87%(+19.6%) |
| Sept 2021 | - | -24.13%(+1.2%) |
| June 2021 | - | -23.85%(-27.7%) |
| Mar 2021 | - | -33.01%(+16.0%) |
| Dec 2020 | -36.30%(+14.5%) | - |
| Dec 2020 | - | -28.46% |
| Dec 2019 | -31.71% | - |
FAQ
- What is Lyell Immunopharma annual return on equity?
- What is the all time high annual ROE for Lyell Immunopharma?
- What is Lyell Immunopharma annual ROE year-on-year change?
- What is Lyell Immunopharma quarterly return on equity?
- What is the all time high quarterly ROE for Lyell Immunopharma?
- What is Lyell Immunopharma quarterly ROE year-on-year change?
What is Lyell Immunopharma annual return on equity?
The current annual ROE of LYEL is -31.53%
What is the all time high annual ROE for Lyell Immunopharma?
Lyell Immunopharma all-time high annual return on equity is -20.77%
What is Lyell Immunopharma annual ROE year-on-year change?
Over the past year, LYEL annual return on equity has changed by -10.76% (-51.81%)
What is Lyell Immunopharma quarterly return on equity?
The current quarterly ROE of LYEL is -33.41%
What is the all time high quarterly ROE for Lyell Immunopharma?
Lyell Immunopharma all-time high quarterly return on equity is -21.13%
What is Lyell Immunopharma quarterly ROE year-on-year change?
Over the past year, LYEL quarterly return on equity has changed by -8.86% (-36.09%)